Log in
Enquire now

List of Genaera patents

List of Genaera patents
List of Spinal Kinetics patents
List of KONTIKI, INC. patents
List of comet (company) patents
List of founders from New York
List of funding rounds for Teleport
Patents where
Current Assignee
Name
is
‌
Genaera
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7410959 Therapeutic uses for aminosterol compounds

Patent 7410959 was granted and assigned to Genaera on August, 2008 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7410959
August 12, 2008
‌
US Patent 7208292 Nucleic acid encoding an interleukin-9 receptor variant

Patent 7208292 was granted and assigned to Genaera on April, 2007 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7208292
April 24, 2007
‌
US Patent 7384767 Nucleic acid encoding an interleukin-9 receptor variant

Patent 7384767 was granted and assigned to Genaera on June, 2008 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7384767
June 10, 2008
‌
US Patent 7192578 Interleukin-9 mutein peptides

Patent 7192578 was granted and assigned to Genaera on March, 2007 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7192578
March 20, 2007
‌
US Patent 7211254 Methods for treating ICACC protein associated diseases

Patent 7211254 was granted and assigned to Genaera on May, 2007 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7211254
May 1, 2007
‌
US Patent 7700088 Interleukin-9 mutein peptides

Patent 7700088 was granted and assigned to Genaera on April, 2010 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7700088
April 20, 2010
‌
US Patent 7704710 Interleukin-9 receptor mutants

Patent 7704710 was granted and assigned to Genaera on April, 2010 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7704710
April 27, 2010
‌
US Patent 7504409 Mucin synthesis inhibitors

Patent 7504409 was granted and assigned to Genaera on March, 2009 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7504409
March 17, 2009
‌
US Patent 7345051 Mucin synthesis inhibitors

Patent 7345051 was granted and assigned to Genaera on March, 2008 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7345051
March 18, 2008
‌
US Patent 7056698 Nucleic acids encoding interleukin-9 receptor variants

Patent 7056698 was granted and assigned to Genaera on June, 2006 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7056698
June 6, 2006
‌
US Patent 6933383 Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols

Patent 6933383 was granted and assigned to Genaera on August, 2005 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
6933383
August 23, 2005
‌
US Patent 7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

Patent 7074778 was granted and assigned to Genaera on July, 2006 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
7074778
July 11, 2006
‌
US Patent 6962909 Treatment of neovascularization disorders with squalimine

Patent 6962909 was granted and assigned to Genaera on November, 2005 by the United States Patent and Trademark Office.

‌
Genaera
United States Patent and Trademark Office
United States Patent and Trademark Office
6962909
November 8, 2005
13 results
0 selected
13 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us